The Effect of Antivascular Endothelial Growth Factor Therapy on the Development of Neovascular Glaucoma after Central Retinal Vein Occlusion: A Retrospective Analysis

Table 1

Demographic and clinical features of patients with ischemic and nonischemic CRVO receiving anti-VEGF for macular edema.

Demographic or clinical variable	Nonischemic (𝑛 = 30)	Ischemic (𝑛 = 14)	𝑃 value
Age	69.5 (11.7)	71.0 (10.4)	0.722
Race
Black	5 (16.7%)	4 (30.8%)	0.627
White	20 (66.7%)	9 (69.2%)
Asian-Indian	1 (3.3%)	0
Initial VA ≤20/200
No	22 (73.3%)	5 (35.7%)	0.021
Yes	8 (26.7%)	9 (64.3%)
VA change
Improved/stable	21 (70.0%)	7 (50.0%)	0.197
Worsened	9 (30.0%)	7 (50.0%)
Ocular NV (NVI, NVD, or VH)
No	29 (96.7%)	9 (64.3%)	0.002
Yes	1 (3.3%)	5 (35.7%)